class name | count |
---|---|
rosids | 10 |
eudicotyledons | 2 |
asterids | 2 |
Liliopsida | 1 |
class name | count |
---|---|
Fabaceae | 5 |
Brassicaceae | 4 |
Enterobacteriaceae | 2 |
Anacardiaceae | 1 |
Iridaceae | 1 |
Nyctaginaceae | 1 |
Plumbaginaceae | 1 |
Plantaginaceae | 1 |
Solanaceae | 1 |
br08003 Category | # of metabolite |
---|
br08003 Category | KEGG ID | KNApSAcK ID |
---|
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00001333
![]() |
beta-Alanine
|
CHEMBL297569
|
8 / 4 / 3 |
![]() |
||
C00001337
![]() |
gamma-Aminobutyric acid
|
CHEMBL96
|
D005680
|
50 / 36 / 27 | 21 / 17 |
![]() |
C00001361
![]() |
Glycine
|
CHEMBL773
|
95 / 37 / 32 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001333 C00001337 C00001361 | 1 / 0 |
Q05BR4 | SLC16A10 protein | Unclassified protein | C00001333 C00001337 C00001361 | 0 / 0 |
Q7Z2H8 | Proton-coupled amino acid transporter 1 | Unclassified protein | C00001333 C00001337 C00001361 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001333 C00001337 C00001361 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001333 C00001337 C00001361 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001333 C00001337 C00001361 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001333 C00001337 C00001361 | 1 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001337 C00001361 | 0 / 0 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00001337 C00001361 | 0 / 0 |
P46098 | 5-hydroxytryptamine receptor 3A | NS | C00001337 C00001361 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001333 C00001337 | 2 / 0 |
P23415 | Glycine receptor subunit alpha-1 | GLR alpha | C00001337 C00001361 | 1 / 1 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001361 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00001361 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00001361 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00001361 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00001361 | 2 / 2 |
P02545 | Prelamin-A/C | Unclassified protein | C00001337 | 11 / 10 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001361 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00001337 | 3 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001337 | 3 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00001361 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 1 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00001337 | 1 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001361 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00001361 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00001361 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001361 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001361 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001361 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00001361 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001361 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001361 | 0 / 0 |
P24046 | Gamma-aminobutyric acid receptor subunit rho-1 | GABA-A rho | C00001337 | 0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00001337 | 1 / 2 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001361 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001361 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001361 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001361 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00001361 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001361 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00001361 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001361 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001361 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001361 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001361 | 1 / 0 |
P48065 | Sodium- and chloride-dependent betaine transporter | Betaine and GABA Na-symporter | C00001337 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001361 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001337 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001337 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001361 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00001361 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00001361 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001361 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00001361 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001361 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00001361 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001361 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00001361 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001361 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001361 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001361 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00001361 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001361 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00001361 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001361 | 0 / 0 |
P11308 | Transcriptional regulator ERG | Unclassified protein | C00001337 | 1 / 2 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001337 | 1 / 2 |
P04150 | Glucocorticoid receptor | NR3C1 | C00001361 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001361 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001361 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001361 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001361 | 2 / 0 |
P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00001337 | 1 / 1 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001361 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001361 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00001361 | 0 / 0 |
Q9UBS5 | Gamma-aminobutyric acid type B receptor subunit 1 | GABA-B receptor | C00001337 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001361 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001361 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001361 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00001361 | 2 / 1 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001361 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00001361 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001361 | 2 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001361 | 2 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001337 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001361 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00001361 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001361 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00001361 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001361 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001361 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00001361 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001361 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00001361 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00001361 | 0 / 0 |
P46059 | Solute carrier family 15 member 1 | Dipeptide | C00001361 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001361 | 0 / 3 |
P30531 | Sodium- and chloride-dependent GABA transporter 1 | GABA | C00001337 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001361 | 0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00001337 | 1 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00001337 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001361 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00001361 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001361 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00001361 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001361 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001337 | 0 / 0 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00001337 | 0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00001337 | 1 / 0 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00001337 | 0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00001337 | 1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00001337 | 0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00001337 | 0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00001337 | 0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00001337 | 0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00001337 | 0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00001337 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00001337 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00001337 | 4 / 2 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00001337 | 0 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00001337 | 0 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00001337 | 1 / 0 |
A8MPY1 | Gamma-aminobutyric acid receptor subunit rho-3 | GABA-A rho | C00001337 | 0 / 0 |
P28476 | Gamma-aminobutyric acid receptor subunit rho-2 | GABA-A rho | C00001337 | 0 / 0 |
P48066 | Sodium- and chloride-dependent GABA transporter 3 | GABA | C00001337 | 0 / 0 |
O75899 | Gamma-aminobutyric acid type B receptor subunit 2 | GABA-B receptor | C00001337 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001337 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
18 | ABAT, GABA-AT, GABAT, NPD009 | 4-aminobutyrate aminotransferase (EC:2.6.1.19 2.6.1.22) |
C00001337
|
1138 | CHRNA5, LNCR2 | cholinergic receptor, nicotinic, alpha 5 (neuronal) |
C00001337
|
1140 | CHRNB1, ACHRB, CHRNB, CMS1D, CMS2A, SCCMS | cholinergic receptor, nicotinic, beta 1 (muscle) |
C00001337
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00001337
|
2550 | GABBR1, GABABR1, GABBR1-3, GB1, GPRC3A, dJ271M21.1.1, dJ271M21.1.2 | gamma-aminobutyric acid (GABA) B receptor, 1 |
C00001337
|
9568 | GABBR2, GABABR2, GPR51, GPRC3B, HG20, HRIHFB2099 | gamma-aminobutyric acid (GABA) B receptor, 2 |
C00001337
|
2554 | GABRA1, ECA4, EJM, EJM5 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
C00001337
|
2555 | GABRA2 | gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
C00001337
|
2557 | GABRA4 | gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
C00001337
|
2558 | GABRA5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
C00001337
|
2559 | GABRA6 | gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
C00001337
|
2560 | GABRB1 | gamma-aminobutyric acid (GABA) A receptor, beta 1 |
C00001337
|
2561 | GABRB2 | gamma-aminobutyric acid (GABA) A receptor, beta 2 |
C00001337
|
2562 | GABRB3, ECA5 | gamma-aminobutyric acid (GABA) A receptor, beta 3 |
C00001337
|
2563 | GABRD, EIG10, EJM7, GEFSP5 | gamma-aminobutyric acid (GABA) A receptor, delta |
C00001337
|
2564 | GABRE | gamma-aminobutyric acid (GABA) A receptor, epsilon |
C00001337
|
2566 | GABRG2, CAE2, ECA2, GEFSP3 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
C00001337
|
2571 | GAD1, CPSQ1, GAD, SCP | glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15) |
C00001337
|
6529 | SLC6A1, GABATHG, GABATR, GAT1 | solute carrier family 6 (neurotransmitter transporter), member 1 |
C00001337
|
6538 | SLC6A11, GAT-3, GAT3, GAT4 | solute carrier family 6 (neurotransmitter transporter), member 11 |
C00001337
|
6540 | SLC6A13, GAT-2, GAT2, GAT3 | solute carrier family 6 (neurotransmitter transporter), member 13 |
C00001337
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 P47869 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#615363 | Estrogen resistance; estrr |
P03372
|
#612219 | Ewing sarcoma; es |
P11308
|
#613163 | Gaba-transaminase deficiency |
P80404
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#149400 | Hyperekplexia, hereditary 1; hkpx1 |
P23415
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00024 | Prostate cancer |
P11308
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00769 | Hyperekplexia |
P23415
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H01257 | GABA-transaminase deficiency |
P80404
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
Q13148
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D001259 | Ataxia |
C00001337
|
D001919 | Bradycardia |
C00001337
|
D002375 | Catalepsy |
C00001337
|
D002389 | Catatonia |
C00001337
|
D019970 | Cocaine-Related Disorders |
C00001337
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001337
|
D004827 | Epilepsy |
C00001337
|
D006429 | Hemiplegia |
C00001337
|
D006973 | Hypertension |
C00001337
|
D007022 | Hypotension |
C00001337
|
D020149 | Manganese Poisoning |
C00001337
|
D009069 | Movement Disorders |
C00001337
|
D012559 | Schizophrenia |
C00001337
|
D012640 | Seizures |
C00001337
|
D013226 | Status Epilepticus |
C00001337
|
D013375 | Substance Withdrawal Syndrome |
C00001337
|
D013610 | Tachycardia |
C00001337
|